Active Ingredient: UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
Proprietary Name: ANORO ELLIPTA
Dosage Form; Route of Administration: POWDER; INHALATION
Strength: EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N203975
Product Number: 001
Approval Date: Dec 18, 2013
Applicant Holder Full Name: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD ENGLAND
Marketing Status:
Prescription
Patent and Exclusivity Information
